U.S. Halts Funding for Deadly Drug Test Strips

The federal government is pulling support for drug test strips, a sharp reversal that could reshape how states and local programs respond to deadly overdoses.

In a letter to states and other grant recipients, the Trump administration said it will stop paying for the strips, according to reports. The administration argues the products encourage drug use, a position that cuts against the approach many public health programs have embraced in recent years. Those programs have treated test strips as a practical tool: a low-cost way to help people identify dangerous substances before they use them.

The move lands in the middle of a long-running fight over harm reduction. Supporters say test strips do not endorse drug use; they acknowledge a deadly reality and try to reduce the odds of death. Critics have long argued that any tool tied to safer use sends the wrong message. This decision gives that argument the force of federal policy, even as communities across the country continue to confront lethal street drug supplies.

The fight over test strips is really a fight over whether policy should focus on deterring drug use at all costs or preventing death first.

What changes on the ground will depend on how heavily states, counties, and nonprofit groups rely on federal grants to buy the strips. Some jurisdictions may try to replace the lost money with state funds or private support. Others may scale back distribution, leaving users with fewer ways to detect substances that reports indicate can appear unpredictably in the illicit drug supply.

The next phase will unfold in budgets, grant rules, and statehouse decisions. If the funding cutoff holds, officials and community groups will face a blunt choice: find other money fast or abandon a tool many see as a frontline defense against overdose. That matters far beyond bureaucratic paperwork, because in the current drug crisis, even small changes in access can carry life-or-death consequences.